Novoseven
Payments companies reported to CMS as associated with Novoseven. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Novoseven, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Novoseven
These are the largest totals companies reported as associated with Novoseven. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Jennifer Domm | Nashville, TN | Pediatric Hematology-Oncology | $39,375.13 |
| Paulette Bryant | Charlotte, NC | Pediatric Hematology-Oncology | $27,798.02 |
| Shveta Gupta | Orlando, FL | Pediatric Hematology-Oncology | $25,136.95 |
| Allison Wheeler | Seattle, WA | Pediatric Hematology-Oncology | $24,890.84 |
| Shayla Bergmann | Beaufort, SC | Pediatric Hematology-Oncology | $21,798.78 |
| Kelly Dawson | Nashville, TN | Pediatrics (Nurse Practitioner) | $19,220.10 |
| Sandeep Rajan | Nashville, TN | Hematology & Oncology | $17,367.40 |
| Akshat Jain | Redlands, CA | Pediatric Hematology-Oncology | $16,811.51 |
| Steven Pipe | Ann Arbor, MI | Pediatric Hematology-Oncology | $16,070.00 |
| Vivek Sharma | Louisville, KY | Hematology & Oncology | $15,247.51 |
Prescribed Novoseven?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.